Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 15;199(2):391-396.
doi: 10.4049/jimmunol.1601882. Epub 2017 Jun 12.

Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgA

Affiliations

Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgA

Olivier Dedobbeleer et al. J Immunol. .

Abstract

Production of active TGF-β is regulated at a posttranslational level and implies release of the mature cytokine dimer from the inactive, latent TGF-β precursor. There are several cell-type specific mechanisms of TGF-β activation. We identified a new mechanism operating on the surface of human regulatory T cells and involving membrane protein GARP, which binds latent TGF-β1. The paracrine activity of regulatory T cell-derived TGF-β1 contributes to immunosuppression and can be inhibited with anti-GARP Abs. Whether other immune cell types use surface GARP to activate latent TGF-β1 was not known. We show in this study that stimulated, human B lymphocytes produce active TGF-β1 from surface GARP/latent TGF-β1 complexes with isotype switching to IgA production.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Human B cells express surface GARP/latent TGF-β1 complexes after in vitro stimulation. (A) Human PBMCs were labeled with anti-GARP (mAb MHG-6) or isotype control Abs and analyzed by flow cytometry. Dot plots are gated on live cells. (B) CD19+ B cells were stimulated or not with anti-IgM/IgG Abs, IL-2, IL-21, sCD40L, and CpG for 24 h. Bar graphs indicate mean GARP mRNA copy numbers normalized to 105 EF-1 mRNA copies (technical duplicates + SD) as determined by quantitative RT-PCR. (C) CD19+ B cells stimulated as in (B) were labeled with Abs against free GARP (mAb MHG-5), total GARP (mAb MHG-6), GARP/TGF-β1 complexes (mAb MHG-8), or LAP, then analyzed by flow cytometry. Histograms are gated on live cells. (D) CD20+CD27 and CD20+CD27+ B cells were stimulated or not as in (B) during the indicated number of days, labeled with Abs against total GARP (mAb MHG-6) and analyzed by flow cytometry. Med. FI: median fluorescence intensity. (E) CD20+CD27 B cells were exposed during 24 h to the indicated stimuli, then labeled with Abs against total GARP (mAb MHG-6) and analyzed by flow cytometry. Histograms are gated on live cells.
FIGURE 2.
FIGURE 2.
Human B cells produce active TGF-β1 in a GARP-dependent manner. (A) Levels of TGFB1, 2 and 3 mRNA were measured in CD19+ B cells stimulated for 24 h with the mixture used in Fig. 1B. Bar graphs indicate mRNA copy numbers normalized to 105 EF-1 mRNA copies (means of duplicates + SD) as determined by quantitative RT-PCR. (B) Total and active TGF-β1 were measured by ELISA in the supernatants of B cells stimulated with the mixture used in Fig. 1B during 4 d in serum-free medium. Means of duplicates + SD. Detection limit: 16 pg/ml. nd, not detected. (C) CD19+ B cells were stimulated as in (A). The indicated Abs (10 μg/ml) were added on day 0 and 3 of the cultures, and rTGF-β1 (0.1 ng/ml) on day 3. Cells collected on day 4 were analyzed by Western blot, and luminescence signals were quantified using Bio1D software. Reduction in pSMAD2/β-actin ratios in cells treated with anti-TGF-β or the blocking anti-GARP MHG-8 Ab (both mIgG1s) are shown relative to the cells stimulated in the presence of a mIgG1 isotype control. Reduction in cells treated with the blocking anti-GARP LHG-10 Ab is shown relative to cells treated with the nonblocking anti-GARP LHG-11 (both hIgG1s). Data are representative of three independent experiments.
FIGURE 3.
FIGURE 3.
Blocking active TGF-β1 production in B cells with anti-GARP blocking Abs decreases IgA class switch. (A) CD20+CD27 B cells were stimulated or not with anti-IgM, sCD40L, IL-2, IL-21, and CpG for 4 d in the presence of the indicated Abs. IgA1 GLT were quantified by quantitative RT-PCR. rTGF-β1 (0.1 ng/ml) added on day 2 was used as positive control. Bar graphs indicate mean IgA1 GLT per 105 EF-1 copies (technical duplicates + SD). (B and C) Naive B lymphocytes were stimulated as above during 7 d, then labeled with anti-IgA, IgG, and IgD and analyzed by flow cytometry. IgD stainings on stimulated and nonstimulated cells are shown in Supplemental Fig. 2G. rTGF-β1 (0.1 ng/ml) added 3 d after stimulation was used as a positive control. Representative contour plots are gated on live cells (B) and bar graphs indicate the mean percentages of six technical replicates ± SD (C). Selected pairs were compared using one-way ANOVA followed by a Bonferroni multiple comparison test. Data are representative of at least three independent experiments. ****p < 0.0001.

Similar articles

Cited by

References

    1. Shull M. M., Ormsby I., Kier A. B., Pawlowski S., Diebold R. J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693–699. - PMC - PubMed
    1. Kulkarni A. B., Huh C. G., Becker D., Geiser A., Lyght M., Flanders K. C., Roberts A. B., Sporn M. B., Ward J. M., Karlsson S. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770–774. - PMC - PubMed
    1. Marie J. C., Liggitt D., Rudensky A. Y. 2006. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25: 441–454. - PubMed
    1. Reed N. I., Jo H., Chen C., Tsujino K., Arnold T. D., DeGrado W. F., Sheppard D. 2015. The αvβ1 integrin plays a critical in vivo role in tissue fibrosis. Sci. Transl. Med. 7: 288ra79. - PMC - PubMed
    1. Munger J. S., Huang X., Kawakatsu H., Griffiths M. J., Dalton S. L., Wu J., Pittet J. F., Kaminski N., Garat C., Matthay M. A., et al. 1999. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319–328. - PubMed

Publication types

MeSH terms